Data as of Sep 17
| -0.07 / -3.08%|
The 2 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 7.57, with a high estimate of 8.36 and a low estimate of 6.78. The median estimate represents a +244.16% increase from the last price of 2.20.
The current consensus among 2 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.